NEW YORK, Sept. 8 (GenomeWeb News) - Linden Bioscience has signed a deal to provide its Tilia oligonucloetide probe design service to Dutch biotech firm PamGene International, the companies said today.

PamGene plans to use the probes with its 5D-Pulse microarray platform, which is the basis for the company's FD10 system and soon-to-be launched PamStation 96 microarray system.

Specific terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.